The relationship between tumor volume changes and serial plasma osteopontin detection during radical radiotherapy of non-small-cell lung cancer

被引:15
|
作者
Ostheimer, Christian [1 ]
Schweyer, Franziska [1 ]
Reese, Thomas [1 ]
Bache, Matthias [1 ]
Vordermark, Dirk [1 ]
机构
[1] Martin Luther Univ Halle Wittenberg, Dept Radiat Oncol, Ernst Grube Str 40, D-06120 Halle, Saale, Germany
关键词
NSCLC; osteopontin; radiotherapy; tumor volume; prognostic factors; RADIATION-THERAPY; PROGNOSTIC-FACTOR; NECK-CANCER; HYPOXIA MARKERS; SURVIVAL; HEAD; CHEMORADIOTHERAPY; OXYGENATION; EXPRESSION; VELOCITY;
D O I
10.3892/ol.2016.5104
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognostic quality of increased osteopontin (OPN) plasma levels has been demonstrated for the chemotherapy and surgery of lung cancer. There is also evidence in the literature that tumor volume impacts prognosis in definitive radiotherapy (RT) of (lung) cancer. We previously demonstrated that elevated plasma levels of OPN before, and increasing OPN plasma levels after RT significantly correlate with survival and outcome after curative-intent RT of non-small-cell lung cancer (NSCLC). Tumor volume was also associated with prognosis. The present prospective clinical study investigated the prognostic interrelation of OPN plasma levels and tumor volume and their changes in the radical RT of NSCLC. We evaluated a subset of patients (n=27) with inoperable, non-metastasized NSCLC of the previously published patient collective. Patients were treated with radical radiochemotherapy (2 Gy ad 66 Gy). OPN plasma concentrations were determined by ELISA before (t0), at the end (t1), and 4 weeks after RT (t2). GTV was delineated PET- and CT-correlated before RT (GTV1) and after 40 Gy (GTV2). The course of OPN during and after RT and the change of GTV during RT was monitored over time and correlated with prognosis. Median GTV2 after 40 Gy (63 ml) was significantly lower than pre-RT GTV1 (90 ml, P<0.0001). Median OPN before (t0), at the end of (t1) and four weeks after RT (t2) was 846, 777 and 624 ng/ml and not significantly different. GTV significantly declined by 39 ml during RT (P<0.0001) and OPN non-significantly decreased by 56 ng/ml during (t0 to t1) and by 54 ng/ml after RT (t1 to t2). No correlations were determined between absolute OPN and GTV values or their relative changes during RT. In univariate analysis, only GTV2 significantly predicted overall survival (OS, P=0.03). In multivariate analysis, both OPN t1 (P<0.001) and GTV2 (P=0.001) remained significant predictors of OS. Relative OPN plasma level changes after (t1 to t2) and GTV changes during RT (GTV 1 to GTV 2) significantly predicted OS (P=0.02). The combination of absolute GTV values before RT (GTV1) and GTV changes during RT (GTV1 to 2) were significantly associated with OS in both uni- and multivariate analysis (P=0.03). The combination of absolute OPN plasma levels and their changes with GTV and its changes did not reach statistical significance. The lack of a significant correlation between OPN and GTV together with the finding that OPN and GTV remained independent predictors of survival outcome but were not associated with OS in combination supports the hypothesis that tumor volume (GTV) and OPN plasma levels (both their changes and absolute values) are not interrelated in terms of prognosis but do possess each parameter separately, a prognostic quality in the radical RT of NSCLC which justifies further prospective studies to validate these results.
引用
收藏
页码:3449 / 3456
页数:8
相关论文
共 50 条
  • [31] DOSE-VOLUME COMPARISON OF PROTON RADIOTHERAPY AND STEREOTACTIC BODY RADIOTHERAPY FOR NON-SMALL-CELL LUNG CANCER
    Kadoya, Noriyuki
    Obata, Yasunori
    Kato, Takahiro
    Kagiya, Masaru
    Nakamura, Tatsuya
    Tomoda, Takuya
    Takada, Akinori
    Takayama, Kanako
    Fuwa, Nobukazu
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (04): : 1225 - 1231
  • [32] The plasma lncRNA acting as fingerprint in non-small-cell lung cancer
    Hu, Xiaodong
    Bao, Jitao
    Wang, Zhen
    Zhang, Zigang
    Gu, Peijie
    Tao, Feng
    Cui, Di
    Jiang, Weilong
    TUMOR BIOLOGY, 2016, 37 (03) : 3497 - 3504
  • [33] The association between osteopontin and survival in non-small-cell lung cancer patients: a meta-analysis of 13 cohorts
    Wang, Ying
    Yang, Jin
    Liu, Hui
    Bi, Ji-Rui
    Liu, Ying
    Chen, Yan-Yan
    Cao, Ji-Yu
    Lu, You-Jin
    ONCOTARGETS AND THERAPY, 2015, 8 : 3513 - 3521
  • [34] Concurrent chemoradiotherapy in locally advanced non-small cell lung cancer: a retrospective analysis of the correlation between radiotherapy-related factors and tumor response
    Park, Y. J.
    Yoon, W. S.
    Lee, J. A.
    Lee, N. K.
    Lee, S.
    Yang, D. S.
    Kim, C. Y.
    Kim, J. H.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2015, 13 (03): : 205 - 212
  • [35] y Role of perilesional edema and tumor volume in the prognosis of non-small cell lung cancer (NSCLC) undergoing radiosurgery (SRS) for brain metastases
    Nardone, Valerio
    Nanni, Sara
    Pastina, Pierpaolo
    Vinciguerra, Claudia
    Cerase, Alfonso
    Correales, Pierpaolo
    Guida, Cesare
    Giordano, Antonio
    Tini, Paolo
    Reginelli, Alfonso
    Cappabianca, Salvatore
    Pirtoli, Luigi
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (08) : 734 - 744
  • [36] Immunohistochemistry for EGFR Mutation Detection in Non-Small-Cell Lung Cancer
    Hitij, Nina Turnsek
    Kern, Izidor
    Sadikov, Aleksander
    Knez, Lea
    Stanic, Karmen
    Zwitter, Matjaz
    Cufer, Tanja
    CLINICAL LUNG CANCER, 2017, 18 (03) : E187 - E196
  • [37] Motion Management for Radical Radiotherapy in Non-small Cell Lung Cancer
    Cole, A. J.
    Hanna, G. G.
    Jain, S.
    O'Sullivan, J. M.
    CLINICAL ONCOLOGY, 2014, 26 (02) : 67 - 80
  • [38] Optimization of volume in radiotherapy of non-small cell lung cancer: small volume
    Emami, B
    TREATMENT OPTIMIZATION FOR LUNG CANCER: FROM CLASSICAL TO INNOVATIVE PROCEDURES, 1998, : 59 - 65
  • [39] Targeting tumor neovasculature in non-small-cell lung cancer
    Pallis, Athanasios G.
    Syrigos, Konstantinos N.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 86 (02) : 130 - 142
  • [40] Metabolic Tumor Volume is an Independent Prognostic Factor in Patients Treated Definitively for Non-Small-Cell Lung Cancer
    Lee, Percy
    Bazan, Jose G.
    Lavori, Philip W.
    Weerasuriya, Dilani K.
    Quon, Andrew
    Quynh-Thu Le
    Wakelee, Heather A.
    Graves, Edward E.
    Loo, Billy W.
    CLINICAL LUNG CANCER, 2012, 13 (01) : 52 - 58